| scholarly article | Q13442814 |
| P50 | author | Stanley B. Prusiner | Q155380 |
| P2093 | author name string | M P McKinley | |
| R K Meyer | |||
| R Cotter | |||
| A Serban | |||
| F Rahbar | |||
| L Kenaga | |||
| P2860 | cites work | Amyloid plaque core protein in Alzheimer disease and Down syndrome | Q24568384 |
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein | Q29547803 | ||
| Immunoaffinity purification and neutralization of scrapie prion infectivity | Q33646402 | ||
| Measurement of the scrapie agent using an incubation time interval assay | Q34270376 | ||
| Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro | Q34350864 | ||
| A cellular gene encodes scrapie PrP 27-30 protein | Q34557641 | ||
| Purified prion proteins and scrapie infectivity copartition into liposomes | Q34630806 | ||
| Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. | Q53186541 | ||
| CNS amyloid proteins in neurodegenerative diseases. | Q53190196 | ||
| Prion-protein immunoreactivity in human transmissible dementias. | Q53193546 | ||
| Structural and biochemical evidence that scrapie-associated fibrils assemble in vivo. | Q54367209 | ||
| PrP and the nature of the scrapie agent | Q60042549 | ||
| Monoclonal antibodies to the cellular and scrapie prion proteins | Q70299710 | ||
| Observations on "dense-body" structure in nerve cells with special reference to scrapie | Q71208638 | ||
| Scrapie-associated fibrils | Q72582604 | ||
| Separation and properties of cellular and scrapie prion proteins | Q35598678 | ||
| Scrapie prion proteins accumulate in the cytoplasm of persistently infected cultured cells | Q36223171 | ||
| Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease | Q36482688 | ||
| Three hamster species with different scrapie incubation times and neuropathological features encode distinct prion proteins | Q36721451 | ||
| Antisera to scrapie-associated fibril protein and prion protein decorate scrapie-associated fibrils | Q36906744 | ||
| Prion liposomes | Q37581303 | ||
| Scrapie prions | Q38365719 | ||
| Sulfated glycosaminoglycans in amyloid plaques of prion diseases | Q39102794 | ||
| Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts). | Q40097698 | ||
| Molecular characteristics of prion rods purified from scrapie-infected hamster brains | Q41341909 | ||
| Distinct prion proteins in short and long scrapie incubation period mice | Q43408194 | ||
| Acceleration of scrapie in neonatal Syrian hamsters | Q43426935 | ||
| Abnormal fibrils from scrapie-infected brain | Q43599868 | ||
| Experimental scrapie in mice: Ultrastructural observations | Q43807813 | ||
| Virus-like particles from both control and scrapie-affected mouse brain | Q44013487 | ||
| Antibodies to the scrapie protein decorate prion rods. | Q44141423 | ||
| Ultrastructural links between scrapie and Alzheimer's disease | Q44247662 | ||
| Isolation of 14-nm virus-like particles from mouse brain infected with scrapie agent | Q44487311 | ||
| Purification and properties of the cellular and scrapie hamster prion proteins | Q45166038 | ||
| Changes in the localization of brain prion proteins during scrapie infection | Q45219246 | ||
| Infection-specific particle from the unconventional slow virus diseases | Q45795964 | ||
| Virus-like particles in brain tissue from two patients with Creutzfeldt-Jakob disease | Q45814329 | ||
| An electron-microscopic study of scrapie in the rat: Further observations on “inclusion bodies” and virus-like particles | Q45815954 | ||
| An electron microscopic study of natural scrapie sheep brain: further observations on virus-like particles and paramyxovirus-like tubules | Q45816851 | ||
| Virus-like particles in natural scrapie of the sheep | Q45825690 | ||
| Virus-like particles and nucleoprotein-type filaments in brain tissue from two patients with Creutzfeldt-Jakob disease | Q45825801 | ||
| An electron microscopic study of the scrapie mouse and rat: further observations on virus-like particles with ruthenium red and lanthanum nitrate as a possible trace and negative stain | Q45826342 | ||
| Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. | Q45962479 | ||
| Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. | Q45979200 | ||
| Rapid detection of Creutzfeldt-Jakob disease and scrapie prion proteins | Q46079042 | ||
| Scrapie prions aggregate to form amyloid-like birefringent rods | Q46201693 | ||
| Immuno-gold localization of prion filaments in scrapie-infected hamster brains | Q46637721 | ||
| Further purification and characterization of scrapie prions | Q46764657 | ||
| Properties of scrapie prion protein liposomes | Q46802500 | ||
| Scrapie prion protein contains a phosphatidylinositol glycolipid | Q46814773 | ||
| Linkage of a prion protein missense variant to Gerstmann-Sträussler syndrome | Q46931937 | ||
| Isolation of low-molecular-weight proteins from amyloid plaque fibers in Alzheimer's disease | Q47208290 | ||
| Isolation and structural studies of the intact scrapie agent protein | Q48190997 | ||
| Identification of prion amyloid filaments in scrapie-infected brain | Q48492399 | ||
| Antibodies to a scrapie prion protein | Q48635549 | ||
| Purification and structural studies of a major scrapie prion protein | Q48639990 | ||
| Scrapie-associated fibrils in Creutzfeldt–Jakob disease | Q48711189 | ||
| Ultrastructural morphology of amyloid fibrils from neuritic and amyloid plaques | Q48812765 | ||
| Aggregations of 35-Nanometer Particles Associated with Neuronal Cytopathic Changes in Natural Scrapie | Q48852636 | ||
| Electron microscopic studies of the brain of sheep with natural scrapie. I. The fine structure of neuronal vacuolation | Q51110184 | ||
| Scrapie in Mice: Ultrastructural Observations in the Cerebral Cortex | Q51194733 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | proteolysis | Q33123 |
| prion protein family | Q24724413 | ||
| P304 | page(s) | 1340-1351 | |
| P577 | publication date | 1991-03-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis | |
| P478 | volume | 65 |
| Q77768801 | A dual pathway for the transmission of spongiform encephalopathy disease |
| Q33697859 | A new method for the characterization of strain-specific conformational stability of protease-sensitive and protease-resistant PrPSc |
| Q33292021 | A novel real-time ultrasonic method for prion protein detection using plasminogen as a capture molecule |
| Q37080692 | A structural overview of the vertebrate prion proteins |
| Q50088409 | Ab initio simulations of Cu binding sites on the N-terminal region of prion protein |
| Q34182647 | Allelic origin of protease-sensitive and protease-resistant prion protein isoforms in Gerstmann-Sträussler-Scheinker disease with the P102L mutation |
| Q36410134 | Alzheimer disease and the prion disorders amyloid beta-protein and prion protein amyloidoses |
| Q46591995 | Assembly of natural and recombinant prion protein into fibrils |
| Q33719644 | Attempts to convert the cellular prion protein into the scrapie isoform in cell-free systems |
| Q33931107 | Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent |
| Q28480480 | Biochemical properties of highly neuroinvasive prion strains |
| Q30881419 | Biochemistry and structure of PrPC and PrPSc |
| Q36039920 | COOH-terminal sequence of the cellular prion protein directs subcellular trafficking and controls conversion into the scrapie isoform |
| Q24299163 | Cdk5: multitasking between physiological and pathological conditions |
| Q27014940 | Cellular aspects of prion replication in vitro |
| Q33558398 | Cellular biology of prion diseases |
| Q64949212 | Changes in proteome solubility indicate widespread proteostatic disruption in mouse models of neurodegenerative disease. |
| Q30368863 | Charge neutralization of the central lysine cluster in prion protein (PrP) promotes PrP(Sc)-like folding of recombinant PrP amyloids. |
| Q41820269 | Cofactor molecules induce structural transformation during infectious prion formation |
| Q73297896 | Comparison of detergent and protease enzyme combinations for the detection of scrapie-associated fibrils from the central nervous system of sheep naturally affected with scrapie |
| Q35539802 | Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. |
| Q39606683 | Copper binding to the PrP isoforms: a putative marker of their conformation and function |
| Q41929003 | Copper induces increased beta-sheet content in the scrapie-susceptible ovine prion protein PrPVRQ compared with the resistant allelic variant PrPARR. |
| Q59419859 | Cu2+ binding triggers αBoPrP assembly into insoluble laminar polymers |
| Q36950666 | Cytosolic proteins lose solubility as amyloid deposits in a transgenic mouse model of Alzheimer-type amyloidosis |
| Q39596556 | Detection of bovine spongiform encephalopathy-specific PrP(Sc) by treatment with heat and guanidine thiocyanate |
| Q36354421 | Diagnostic approaches for viruses and prions in stem cell banks |
| Q46085566 | Discovering DNA encodes heredity and prions are infectious proteins |
| Q34296117 | Distinct stability states of disease-associated human prion protein identified by conformation-dependent immunoassay |
| Q34375245 | Evidence for assembly of prions with left-handed beta-helices into trimers |
| Q27336314 | Ex vivo mammalian prions are formed of paired double helical prion protein fibrils. |
| Q37869096 | Fate of prions in soil: a review |
| Q36601530 | From conversion to aggregation: protofibril formation of the prion protein |
| Q30493393 | GPI anchoring facilitates propagation and spread of misfolded Sup35 aggregates in mammalian cells |
| Q41689443 | Genetics of prions |
| Q24294784 | Gerstmann-Sträussler-Scheinker disease amyloid protein polymerizes according to the "dock-and-lock" model |
| Q30492360 | Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions |
| Q45935884 | Glycosylinositol phospholipid anchors of the scrapie and cellular prion proteins contain sialic acid |
| Q33556069 | Glycosylphosphatidylinositol anchoring directs the assembly of Sup35NM protein into non-fibrillar, membrane-bound aggregates |
| Q39431937 | Implications of peptide assemblies in amyloid diseases |
| Q35122360 | In vitro conversion of normal prion protein into pathologic isoforms |
| Q34232938 | Inactivation of prions by acidic sodium dodecyl sulfate |
| Q81316664 | Influence of water, fat, and glycerol on the mechanism of thermal prion inactivation |
| Q34304967 | Interactions and conversions of prion protein isoforms |
| Q73442688 | Kinetics and mechanism of amyloid formation by the prion protein H1 peptide as determined by time-dependent ESR |
| Q40569086 | Knock-down of the 37-kDa/67-kDa laminin receptor in mouse brain by transgenic expression of specific antisense LRP RNA. |
| Q39004344 | Mammalian prions and their wider relevance in neurodegenerative diseases |
| Q35194912 | Mammalian prions: tracking the infectious entities |
| Q32003051 | Mapping the prion protein using recombinant antibodies |
| Q36497270 | Mechanisms of prion protein assembly into amyloid |
| Q33403195 | Methionine sulfoxides on prion protein Helix-3 switch on the alpha-fold destabilization required for conversion. |
| Q43433755 | Modeling the interplay of glycine protonation and multiple histidine binding of copper in the prion protein octarepeat subdomains. |
| Q36063397 | Molecular biology and genetics of neurodegenerative diseases caused by prions |
| Q36477026 | Molecular biology and pathology of scrapie and the prion diseases of humans |
| Q36538997 | Molecular biology and transgenetics of prion diseases |
| Q36315505 | Mouse-adapted ovine scrapie prion strains are characterized by different conformers of PrPSc |
| Q34434726 | Mouse-adapted scrapie infection of SN56 cells: greater efficiency with microsome-associated versus purified PrP-res |
| Q35469443 | Natural and experimental prion diseases of humans and animals |
| Q37386047 | Natural and synthetic prion structure from X-ray fiber diffraction |
| Q36676179 | Novel aspects of prions, their receptor molecules, and innovative approaches for TSE therapy |
| Q57825416 | Observing fibrillar assemblies on scrapie-infected cells |
| Q21559510 | Oral transmissibility of prion disease is enhanced by binding to soil particles |
| Q46913957 | Parameters that affect macromolecular self-assembly of prion protein |
| Q46894080 | Pathologic conformations of prion proteins |
| Q37560815 | PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection |
| Q36099038 | PrPc does not mediate internalization of PrPSc but is required at an early stage for de novo prion infection of Rov cells |
| Q27660444 | Prion Fibrillization Is Mediated by a Native Structural Element That Comprises Helices H2 and H3 |
| Q36549301 | Prion Protein Genes: Evolutionary and Functional Aspects |
| Q34294957 | Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein |
| Q33764321 | Prion protein interconversions and the transmissible spongiform encephalopathies |
| Q37448617 | Prion protein misfolding, strains, and neurotoxicity: an update from studies on Mammalian prions |
| Q28776299 | Prion protein: evolution caught en route |
| Q24633319 | Prions |
| Q48220367 | Prions and related neurological diseases |
| Q36667738 | Prions and the potential transmissibility of protein misfolding diseases |
| Q37135772 | Prions in the environment: occurrence, fate and mitigation |
| Q34413061 | Prions. |
| Q35763573 | Prions: so many fibers, so little infectivity |
| Q30369454 | Progress towards structural understanding of infectious sheep PrP-amyloid. |
| Q33937407 | Pros and cons of a prion-like pathogenesis in Parkinson's disease |
| Q41986349 | Proteinase K-sensitive disease-associated ovine prion protein revealed by conformation-dependent immunoassay |
| Q92135625 | Recent Advances in Understanding Mammalian Prion Structure: A Mini Review |
| Q37096971 | Recombinant scrapie-like prion protein of 106 amino acids is soluble |
| Q42949808 | SAXS structural study of PrP(Sc) reveals ~11 nm diameter of basic double intertwined fibers |
| Q41755024 | Scrapie infectivity is independent of amyloid staining properties of the N-terminally truncated prion protein |
| Q33930771 | Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody |
| Q33911902 | Search for a prion-specific nucleic acid |
| Q28189500 | Shattuck lecture--neurodegenerative diseases and prions |
| Q36280032 | Solid-state NMR studies of the prion protein H1 fragment |
| Q41693538 | Stable isotope-labeled peptides in study of protein aggregation |
| Q33837020 | Strain-specified characteristics of mouse synthetic prions |
| Q28361583 | Strain-specified relative conformational stability of the scrapie prion protein |
| Q39047631 | Structural Biology of PrP Prions |
| Q36693082 | Structural models of amyloid-like fibrils |
| Q34019102 | Structural studies of the scrapie prion protein by electron crystallography |
| Q46025414 | Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. |
| Q35221753 | Structural studies of truncated forms of the prion protein PrP. |
| Q34337663 | Synthetic mammalian prions |
| Q39856446 | The 37/67 kDa laminin receptor (LR) inhibitor, NSC47924, affects 37/67 kDa LR cell surface localization and interaction with the cellular prion protein. |
| Q33874865 | The core of Ure2p prion fibrils is formed by the N-terminal segment in a parallel cross-β structure: evidence from solid-state NMR. |
| Q28473010 | The octarepeat region of the prion protein is conformationally altered in PrP(Sc) |
| Q41728758 | The prion domain of yeast Ure2p induces autocatalytic formation of amyloid fibers by a recombinant fusion protein |
| Q34177517 | The role of dimerization in prion replication |
| Q43068298 | The structural intolerance of the PrP alpha-fold for polar substitution of the helix-3 methionines |
| Q39645458 | Three-dimensional structure of the lithostathine protofibril, a protein involved in Alzheimer's disease |
| Q41143203 | Transgenic and knockout mice in the study of neurodegenerative diseases |
| Q34306678 | Transmissible spongiform encephalopathies and prion protein interconversions |
| Q37135562 | Truncated forms of the prion protein PrP demonstrate the need for complexity in prion structure. |
| Q36719959 | Ultrastructural Studies of Prions |
| Q34169742 | Ultrastructural studies on scrapie prion protein crystals obtained from reverse micellar solutions |
| Q48612578 | Use of capillary sodium dodecyl sulfate gel electrophoresis to detect the prion protein extracted from scrapie-infected sheep. |
| Q36970419 | Vulnerability of newly synthesized proteins to proteostasis stress |
Search more.